Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S , M.C.P.S , M.R.C.G.P (Internal Medicine) , Certified Diabetologist
Internal Medicine Specialist
M.B.B.S , M.C.P.S , M.R.C.G.P (Internal Medicine) , Certified Diabetologist
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, MCPS, FCPS, MCFP(Canada)
General Physician
MBBS, FCPS
Endocrinologist
MBBS (Gold Medalist), FCPS (Internal Medicine), F.C.P.S. (Endocrinology), Fellowship in Diabetes, Endocrine and Metabolism(AKUH), SCE Endocrine & Diabetes (UK)
Endocrinologist
MBBS (Gold Medalist), FCPS (Internal Medicine), F.C.P.S. (Endocrinology), Fellowship in Diabetes, Endocrine and Metabolism(AKUH), SCE Endocrine & Diabetes (UK)
Internal Medicine Specialist
M.B.B.S, Diploma in Family Medicine (DFM), M.C.P.S
Internal Medicine Specialist
M.B.B.S, Diplomate of American Board (Internal Medicine)
Internal Medicine Specialist
M.B.B.S, Diplomate of American Board (Internal Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures